Clinical trial
Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced…
NCT00399256 · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF), Other · Terminated
Key facts
| NCT number | NCT00399256 |
|---|---|
| Title | Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn |
| Official title | Improved Estimation of Glomerular Filtration Rate by Serum Cystatin C in Preventing Contrast Induced Nephropathy by N-Acetylcysteine or Zinc |
| Lead sponsor | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF), Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Kidney Failure |
| Intervention type | Drug |
| Interventions | Acetylcysteine, Zinc |
| Enrollment | 60 |
| Start date | Mar 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Nov 14, 2006 |
| Last update posted | Feb 1, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: